Last reviewed · How we verify
Routine continuous cluster of Alutard SQ
Alutard SQ is an allergen immunotherapy product that desensitizes patients to specific allergens through gradual dose escalation.
Alutard SQ is an allergen immunotherapy product that desensitizes patients to specific allergens through gradual dose escalation. Used for Allergic rhinitis and/or allergic asthma caused by specific allergens (e.g., pollen, dust mites, animal dander).
At a glance
| Generic name | Routine continuous cluster of Alutard SQ |
|---|---|
| Sponsor | Beijing Tongren Hospital |
| Drug class | Allergen immunotherapy (subcutaneous immunotherapy, SCIT) |
| Modality | Biologic |
| Therapeutic area | Allergy/Immunology |
| Phase | FDA-approved |
Mechanism of action
Alutard SQ works by administering increasing doses of allergen extract subcutaneously to induce immune tolerance. This process shifts the immune response from IgE-mediated (allergic) to IgG-mediated (protective) antibodies, and increases regulatory T cells, thereby reducing allergic symptoms upon natural allergen exposure.
Approved indications
- Allergic rhinitis and/or allergic asthma caused by specific allergens (e.g., pollen, dust mites, animal dander)
Common side effects
- Local injection site reactions (erythema, swelling, pruritus)
- Systemic allergic reactions
- Anaphylaxis
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |